findmyKOL

Matthew Pipeling, MD

Basic profile

Duke University

ORCIDNone on fileNPI
RegionDurham, NC · SoutheastSpecialtyPulmonary DiseaseFocusRespiratory
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Matthew Pipeling is a Respiratory physician affiliated with Duke University. OpenAlex indexes 27 publications with 1,510 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
27publications

Distinct works indexed by OpenAlex.

1,510citations

Total citations across indexed works.

15h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    24.6%
    Short-acting sulfonamides12.3%
    Sulfamethoxazole-Trimethoprim100%
    Part D58 patients
    Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor5%
    Valganciclovir Hcl100%
    Part D28 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    21.6%
    Proton pump inhibitor8.9%
    Pantoprazole Sodium50%Omeprazole26%Esomeprazole Magnesium24%
    Part D<11 patients
    Corticosteroid8.6%
    Prednisone100%
    Part D46 patients

    + 4 more classes in this area

  • Cardiovascular

    18.3%
    Beta blocker7.6%
    Carvedilol41%Metoprolol Tartrate31%Propranolol Hcl17%Metoprolol Succinate10%
    Part D<11 patients
    Statin6.6%
    Pravastatin Sodium44%Rosuvastatin Calcium43%Atorvastatin Calcium13%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”